Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07009210 · ClinicalTrials.gov registry record · NA
AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness
A NA study of Serious Illness and Existential Distress, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT07009210: Recruiting NA study of Serious Illness and Existential Distress, sponsored by Mayo Clinic.
NCT07009210 is a NA study of Serious Illness and Existential Distress that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07009210, a NA study of Serious Illness and Existential Distress, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
Primary Outcome
Study feasibility will be measured by the number of participants who enrolled and finished the study.
Conditions Studied
Interventions
- BEHAVIORAL AI Assisted Personalized Legacy Program
Study Locations (2)
Arizona
- Mayo Clinic - Phoenix
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-08-11 |
| Est. Completion | 2027-06 |
| Phase | NA |
What NCT07009210 shows while recruiting
NCT07009210 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Serious Illness appearing as the primary indexed condition, and to 1 intervention - of which AI Assisted Personalized Legacy Program is the first listed.
NCT07009210 reports a single indexed study location in Arizona, Minnesota.
Frequently Asked Questions
What is clinical trial NCT07009210 about?
NCT07009210 is a clinical study titled "AI Assisted Personalized Legacy Program (Reflections: My Story) for Patients With Serious Illness". The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the AI Assisted Personalized Legacy Program intervention to patients with serious illness.
What is the current status of trial NCT07009210?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-08-11. Estimated completion is 2027-06.
What conditions does trial NCT07009210 study?
This clinical trial studies the following conditions: Serious Illness, Existential Distress.
What interventions are being tested in trial NCT07009210?
The interventions under investigation include: AI Assisted Personalized Legacy Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07009210?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07009210 being conducted?
This trial has 2 study locations across Arizona, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Serious Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07009210's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI